Fever is a common symptom in clinical practice, often indicating an underlying infection or inflammation. Despite its ubiquity, its management can pose challenges due to the myriad of potential causes and the diversity of patient responses. This article aims to provide a comprehensive guide to managing fever in clinical practice.
Fever is not a disease but a physiological response to a variety of conditions, predominantly infection. The febrile response is a complex physiological process involving cytokines, prostaglandins, and the hypothalamic-pituitary-adrenal axis. Recognizing fever as a symptom rather than a disease can guide clinicians towards a more patient-specific approach in management.
Assessing a patient with fever begins with a detailed history and physical examination. The history should focus on the onset, duration, and pattern of the fever, associated symptoms, travel history, and exposure to infectious agents. Physical examination may reveal localized signs of infection or systemic signs of inflammation. Laboratory investigations, including complete blood count, blood cultures, and inflammatory markers, can aid in identifying the underlying cause.
Antipyretic therapy is not always necessary and should be tailored to the patient's comfort and underlying condition. Non-pharmacological methods such as tepid sponging and adequate hydration can be effective in managing discomfort associated with fever. Pharmacological interventions, including acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs), can be used for symptom relief. However, the primary focus should be on treating the underlying cause of the fever.
Special considerations are necessary in certain populations, such as infants, elderly patients, and immunocompromised individuals. In these patients, fever may be the only sign of a serious underlying condition, necessitating prompt evaluation and treatment. Additionally, these patients may not mount a typical febrile response, making diagnosis and management more challenging.
Regular monitoring of the patient's temperature and response to treatment is crucial. Persistent or recurrent fever despite appropriate treatment may indicate a more serious underlying condition or a complication. Follow-up is essential to ensure resolution of the fever and to monitor for potential relapses or complications.
Managing fever in clinical practice requires a comprehensive understanding of its physiological basis, a systematic approach to diagnosis, and a patient-specific treatment strategy. Special considerations are necessary for certain populations, and regular monitoring and follow-up are crucial to ensure optimal patient outcomes. By adopting these strategies, clinicians can effectively manage fever and improve patient care.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation